Patent application number | Description | Published |
20100009992 | AMPK MODULATORS - The present invention relates to compounds and pharmaceutically acceptable salts, esters and prodrugs of Formula (I) or (II): | 01-14-2010 |
20110098323 | INHIBITORS OF BACTERIAL BIOFILM FORMATION - Organic compounds are described for use in inhibiting or preventing formation of bacterial biofilms. | 04-28-2011 |
20120094971 | Compositions Including 6-Aminohexanoic Acid Derivatives As HDAC Inhibitors - This invention relates to compounds of Formula (I) wherein Cy | 04-19-2012 |
20120189614 | INHIBITORS OF FILOVIRUS ENTRY INTO HOST CELLS - Organic compounds showing the ability to inhibit viral glycoprotein (GP)-mediated entry of a filovirus into a host cell are disclosed. The disclosed filovirus entry inhibitor compounds are useful for treating, preventing, or reducing the spread of infections by filovirus including the type species Marburg virus (MARV) and Ebola virus (EBOV). Preferred inhibitors of the invention provide therapeutic agents for combating the Ivory Coast, Sudan, Zaire, Bundibugyo, and Reston Ebola virus strains. | 07-26-2012 |
20120302576 | AMPK MODULATORS - The present invention relates to compounds and pharmaceutically acceptable salts, esters and prodrugs of Formula (I) or (II): | 11-29-2012 |
20130317003 | Histone Deacetylase Inhibitors - This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3). | 11-28-2013 |
20130331456 | INHIBITORS OF VIRAL ENTRY INTO MAMMALIAN CELLS - The present invention is related to the development of compounds and methods for inhibiting viral infection in a mammal. A pseudotype virus was developed for use in a high throughput assay for identifying nonpeptidic small molecule inhibitors that prevent viral entry into a host cell. | 12-12-2013 |
20140051680 | Histone Deacetylase Inhibitors - This invention relates to generally inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3). | 02-20-2014 |
20140142134 | INHIBITORS OF BACTERIAL TYPE III SECRETION SYSTEM - Organic compounds showing the ability to inhibit effector toxin secretion or translocation mediated by bacterial type III secretion systems are disclosed. The disclosed type III secretion system inhibitor compounds are useful for combating infections by Gram-negative bacteria such as | 05-22-2014 |